Dr. Reddy's Laboratories logo
RDDA logo

Dr. Reddy's LaboratoriesDB:RDDA Stock Report

Market Cap €11.3b
Share Price
n/a
1Y-0.8%
7D-1.5%
Portfolio Value
View

Dr. Reddy's Laboratories Limited

DB:RDDA Stock Report

Market Cap: €11.3b

My Notes

Capture your thoughts, links and company narrative

Dr. Reddy's Laboratories Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Dr. Reddy's Laboratories
Historical stock prices
Current Share Price₹13.10
52 Week High₹15.20
52 Week Low₹12.40
Beta0.36
1 Month Change-13.25%
3 Month Change-2.96%
1 Year Change-0.76%
3 Year Change28.43%
5 Year Change61.33%
Change since IPO128.78%

Recent News & Updates

Recent updates

Shareholder Returns

RDDADE PharmaceuticalsDE Market
7D-1.5%1.5%1.9%
1Y-0.8%-7.6%15.1%

Return vs Industry: RDDA exceeded the German Pharmaceuticals industry which returned -7.6% over the past year.

Return vs Market: RDDA underperformed the German Market which returned 15.1% over the past year.

Price Volatility

Is RDDA's price volatile compared to industry and market?
RDDA volatility
RDDA Average Weekly Movement3.7%
Pharmaceuticals Industry Average Movement5.3%
Market Average Movement4.8%
10% most volatile stocks in DE Market11.3%
10% least volatile stocks in DE Market2.4%

Stable Share Price: RDDA has not had significant price volatility in the past 3 months compared to the German market.

Volatility Over Time: RDDA's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
198427,048Erez Israeliwww.drreddys.com

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segments. The company’s Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business.

Dr. Reddy's Laboratories Limited Fundamentals Summary

How do Dr. Reddy's Laboratories's earnings and revenue compare to its market cap?
RDDA fundamental statistics
Market cap€11.29b
Earnings (TTM)€597.52m
Revenue (TTM)€3.47b

18.9x

P/E Ratio

3.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
RDDA income statement (TTM)
Revenue₹311.31b
Cost of Revenue₹126.66b
Gross Profit₹184.65b
Other Expenses₹130.97b
Earnings₹53.68b

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)64.43
Gross Margin59.31%
Net Profit Margin17.24%
Debt/Equity Ratio14.4%

How did RDDA perform over the long term?

See historical performance and comparison

Dividends

0.7%

Current Dividend Yield

12%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/02 03:59
End of Day Share Price 2025/01/31 00:00
Earnings2024/12/31
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Dr. Reddy's Laboratories Limited is covered by 85 analysts. 37 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Prashant NairAmbit Capital
Nitin BhasinAmbit Capital
Sriraam RathiAnand Rathi Shares and Stock Brokers Limited